Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study

Fig. 2

Most frequent sources of infection recorded and treated on admission in 359 patients (a), during the 30 days of follow-up for 340 of them (b) and in another 226 AIT-free patients on admission treated after day 0 and before day 30 (c). AF, antifungal therapy; AG, aminoglycosides; AGP, anti-Gram-positive agents; BL, beta-lactams; CP, carbapenems; CRI, catheter-related infection; UTI, urinary tract infection; SSTI, skin and soft tissue infection

Back to article page